1 FEDERAL REPUBLIC OF NIGERIA ANTICOUNTERFEITING ACTIVITES: THE CASE OF NIGERIA PROF. DORA N. AKUNYILI DIRECTOR-GENERAL NATIONAL AGENCY FOR FOOD AND.

Slides:



Advertisements
Similar presentations
The organisation of labour inspection in France. Labour inspection within the Ministry of Labour Centre C Competition Consumer spending Fraud prevention.
Advertisements

Combating Counterfeit Drugs in China Chen Xu Ph.D. Director of Division of Drug Supervision and Inspection Department of Drug Market.
International Medical Products Anti-CounterfeitingTaskforce INSPECTOR OF DRUGS NATIONAL DRUG AUTHORITY- UGANDA.
International Medical Products Anti-CounterfeitingTaskforce.
Promoting patient-centred healthcare around the world Advancing the fight against counterfeit medicines Ms. Regina Kamoga IAPO Board Member, Country Manager,
U. S. Customs and Border Protection Trade Priorities June 16, 2010.
Panel themes of the International Conference “Europe against Counterfeit Medicines” G.N. Gildeeva, Deputy head of the Department of Registration of Medicines.
Medicines Transparency Alliance30/04/ Improving Medicines Quality in Ghana through Routine GPHF-Minilab® Daniel Kojo Arhinful, Senior Technical Advisor,
- 0 - Medicines manufactured under these conditions What do you want your Patients to receive??
PAN INDIA OPERATIONS India’s Exclusive Full Spectrum Business Risk Solutions Enterprise SUBSTANTIVE CHALLENGES IN INTELLECTUAL PROPERTY PROTECTION IN INDIA.
Product Conformity Assessment (PCA) September 2013.
Introduction to Treat the Pain. The problem of unrelieved pain Globally, 7.3 million people die of cancer or HIV each year in moderate or severe pain.
Rational Use of Injections within National Drug Policies World health organisation Essential Drugs and Medicines Policy Safe Injection Global Network Cairo.
Health Aspect of Disaster Risk Assessment Dr AA Abubakar Department of Community Medicine Ahmadu Bello University Zaria Nigeria.
Essential Drugs Programme
Unit 4: Monitoring Data Quality For HIV Case Surveillance Systems #6-0-1.
Fire Safety Jonathan Harrison Fire Protection Inspector West Yorkshire Fire & Rescue Authority.
The Sixth Annual African Consumer Protection Dialogue Conference
The National Injury Prevention Program of the Hospital for Sick Children Safe Kids Canada; Product Safety and Child and Youth Injury Prevention ICPHSO.
A Common Immigration Policy for Europe Principles, actions and tools June 2008.
©2014 First Conference of Regulatory Authorities in Sudan and Neighbouring Countries Khartoum, 6-8 December 2014 Dr Lembit Rägo Head, Regulation of Medicines.
12, 2916 – 5 th Avenue Calgary, Alberta, T2A 6K4, Canada Phone: + 1 (403) , Fax: + 1 (403) Website:
THE HIGHLIGHTS OF DRUG REGULATION IN KENYA. Presentation by: Dr. Joseph K. Yano B.Pharm (Nbi) L.L.B (Moi) Legal Officer Pharmacy and Poisons Board Ministry.
USERS’ INVOLVEMENT IN MENTAL HEALTH WORK. By Sylvester Katontoka
SCHOOL OF MEDIA AND COMMUNICATION The Practice and Prospects of Corporate Governance in Africa Dr. Mike Okolo School of Media & Communication Pan-African.
1 Examples of subregional collaboration: the experience of Operation Mamba I & II in East African Community (EAC) The case of TANZANIA IMPACT.
And Pharmaceuticals Health Technology Technical Cooperation for Essential Drugs and Traditional Medicine Challenges of Medicine Regulation in Africa Global.
Control Risks Group w w w. c r g. c o m CR G Managing Risks in Africa to Maximise Opportunity Matthew Durdy Director, EMEA Control Risks Group
Moving Forward With the African Dialogue Cross-Border Principles By Mary Gurure Manager, Legal Services and Compliance COMESA Competition Commission Lilongwe,
African Business Leaders on Health: GBC Conference on TB, HIV-TB Co-infection & Global Fund Partnership Johannesburg, October 11, 2010 The state of Global.
1 OIE Response to the HPAI Threat in the SADC Region 1 st SADC Meeting on Avian Influenza Pretoria, South Africa 7-9 March 2006 Sub Regional Representation.
Promoting CARICOM/CARIFORUM Food Security (Project GTFS/RLA/141/ITA) (FAO Trust Fund for Food Security and Food Safety – Government of Italy Contribution)
Crosswalk of Public Health Accreditation and the Public Health Code of Ethics Highlighted items relate to the Water Supply case studied discussed in the.
Important informations
European Commission Rita L’ABBATE Legal aspects linked to internal market DG Enterprise and Industry MARKET SURVEILLANCE COMMUNITY FRAMEWORK UNECE “MARS”
Zambia’s Porous Borders & the Influx of Medicines.
Social Pharmacy Lecture no. 6 Rational use of drugs Dr. Padma GM Rao
OVERVIEW OF HIV/AIDS IN AFRICA INTRODUCTION As of December 1999, the United Nations Programme on HIV/AIDS estimated that 33.6 million people worldwide.
“Grassroots Leverage” In partnership with
1 Good Intentions – Bad Drugs Washington, DC Thursday, 10 March 2005 Robert D. Moore, Executive Director; Global Security Group Merck & Co., Inc.
Bad intentions - good policies: Who wins? Case exercise and role play on drug counterfeiting in an LDC context World Bank Case Exercise – all names and.
Banning Forms of Alcohol Advertising. Background  Injuries  Liver cirrhosis  Cancers  Cardiovascular diseases  Premature deaths  Poverty  Family.
WHO-Technical Briefing Seminar | October-November 2012 Dr Cécile Macé 1 |1 | Good Governance for Medicines Programme Dr Cécile Macé EMP/MPC.
Food Safety – An Issue of Public Health Concern
“Grassroots Leverage” In partnership with
THE ROLE OF WHO, UNICEF AND NEPAD IN NURSING UNICEF WHO.
OSHA Guidelines for Employers to Reduce Motor Vehicle Crashes
PHARMACOVIGILANCE PLAN FOR TANZANIA PREPARED BY EMMA & MARY 10 TH SEPTEMBER 2004.
WHO Medicines Strategy Progress: Priorities: Dr Guitelle Baghdadi Essential Drugs and Medicines Policy World Health Organization November.
IMPACT - Regional Meeting on Combating Counterfeit Medical Products 9-10 November 2009, Kempton Park South Africa WHO Survey on situation of counterfeit.
Audit Oversight in an Emerging Economy Bernard Peter Agulhas Chief Executive Officer Independent Regulatory Board for Auditors.
Launch of the INCB Annual Reports March 2016.
IPR Enforcement in the United Kingdom Kenny Wright Danish Patent and Trademark Office.
1 CHALLENGES IN REGULATING QUALITY AND RATIONAL USE OF ANTIBIOTICS ALLIANCE FOR THE PRUDENT USE OF ANTIBIOTICS: INAGURAL MEETING COURTYARD.
Steps for the Integration of Traditional Medicine in the National Health Care Delivery System 18 TH ICASA Special Session on Traditional Medicine 1 st.
Prepared by: Imon Rahman Lecturer Department of Pharmacy BRAC University.
Dr. Sarah A. H Olembo, Technical expert and advisor-SPS and Food safety, RURAL ECONOMY and AGRICULTURE, AFRICAN UNION COMMISSION ADDIS ABABA, ETHIOPIA.
THE OFFICE FOR REGISTRATION OF MEDICINAL PRODUCTS, MEDICAL DEVICES AND BIOCIDAL PRODUCTS Responsibility in the handling of medical devices.
Quality of Drugs in Private Pharmacies in Laos: A Repeated Study in 1997 and 1999 Stålsby Lundborg C, Syhakhang L, Lindgren B, Tomson G International Health.
FUNDAMENTALS OF PUBLIC HEALTH Joseph S Duren Lopez Community & Public Health - HCA415 Instructor: Adriane Niare November 10, 2015.
ITC-ILO/ACTRAV Course A Trade Union Training on Occupational Safety, Health & HIV/AIDS (26/11 – 07/12/2012, Turin) Introduction to National Occupational.
INTRODUCTION A national drug policy is a document which covers all the areas and issues related to drugs. This document outlines all aspects of drugs.
ACCESS TO QUALITY MEDICINES IN THE REGION-COUNTERFEITING PROBLEMS
FIGHTING ANTICOMPETITIVE BUSINESS PRACTICES IN THE MALAWI SUGAR INDUSTRY 2nd ANNUAL COMPETITION AND ECONOMIC REGULATION (ACER) WEEK SOUTHERN AFRICA LIVINGSTONE,
Developing pharmacovigilance: new challenges and opportunities Mary Couper and Shanthi Pal Quality Assurance and Safety of Medicines.
The Sub-Regional Integrity Conference (Almaty, Kazakhstan, January 2007) «Strategic methods of improving integrity in Customs» Global Forum V.
Fight Against Falsified medicines
SRO APPROACH TO REGULATION
Stakeholder Engagement Meeting
NIGERIAN REGISTRATION SYSTEMS OF VETERINARY MEDICINAL PRODUCTS :
Presentation transcript:

1 FEDERAL REPUBLIC OF NIGERIA

ANTICOUNTERFEITING ACTIVITES: THE CASE OF NIGERIA PROF. DORA N. AKUNYILI DIRECTOR-GENERAL NATIONAL AGENCY FOR FOOD AND DRUG ADMINISTRATION AND CONTROL (NAFDAC), NIGERIA. PRESENTATION TO WORKING CUSTOMS SEMINAR ON THE FIGHT AGAINST FRAUD AND COUNTERFEITING IN WESTERN AFRI CA ORGANISED BY AFRICAN INDUSTRAL ASSOCIATION IN PARTNERSHIP WITH WESTAFRICAN ECONOMIC AND MONETRY UNION (WAEMU) & THE EUROPIAN COMMISSION AT OUAGADOUGU, BURKINA FASO NOVEMBER 28th – 30th, 2005.

3 OUTLINE Introduction. What is a Counterfeit Medicine Implications of Counterfeit Drugs Scope of the Problem of Fake/Counterfeit Drugs in Nigeria Prior Factors that encourage drug counterfeiting. Strategies employed by NAFDAC to Combat Drug Counterfeiting in Nigeria. Government Support Some of the Achievements and Gains Recorded so Far. Conclusion

4 INTRODUCTION BACKGROUND INFORMATION Nigeria is a country in west Africa bordered to the East by Cameroun, the West by Benin Republic, the North by Niger Republic, North East by Chad and South by Atlantic Ocean. POPULATION: Approx.150million TOTAL AREA: 923,768Sq/Km LAND AREA: 910,768Sq/Km WATER : 13,OOOSq/Km GEO-POLITICAL ZONES:Six(6) NO. OF STATES:36 CAPITAL: Abuja OFFICIAL LANGUAGE: English

5 INTRODUCTION CONTD I am excited to have been invited to address this distinguished audience on a global burning issue, that is of interest not only to Drug regulatory authority but also the custom organizations. I have also been privileged to participate in the 1 st and 2 nd Global Fora on Pharmaceutical anti-counterfeiting, organized by Reconnaissance International in Geneva and Paris, September 2002 and March 2005, respectively. More recently we have equally shared our experience of anticounterfeiting activities with regulatory authorities from francophone west African countries in Senegal in October 2005 I use the opportunities of such meetings to tell the world that drug counterfeiting is a reality, Share strategies that we have used in combating it, - So that countries that have already been invaded by drug counterfeiters will learn from our experience and know that it is possible to fight and defeat them despite the daunting constraints, - And countries without reports of counterfeit drugs to be proactive so as not to give drug counterfeiters the opportunity to come in and establish their network.

6 INTRODUCTION CONTD Drug counterfeiters have succeeded in the past three decades largely because of lack of awareness and lack of cooperation among stakeholders nationally and internationally. The increasing worldwide reports of counterfeit medicines and the number of international fora focusing on drug counterfeiting, have sensitized all stakeholders including security operatives as yours to collaborate on the need to work together in order to make it difficult for drug counterfeiters to continue thriving in their nefarious activities. The negative impact of counterfeit drugs knows no boundaries and affects the health, social and economic life of all nations, therefore a forum such as this with officers versed in investigative skills is ideal for pooling resources to frustrate drug counterfeiters. At the end of this presentation I expect that we would all have learnt and imbibed the need for collaborative effort between customs and regulatory authorities, also between Nations of the world especially in the sub- region.

7 WHAT IS A COUNTERFEIT MEDICINE NAFDAC identified forms of fake/counterfeit drugs: Drugs with no active ingredient(s) Drugs with insufficient active ingredients Drugs with active ingredient(s) different from what is stated on the packages Clones of fast moving drugs - these are drugs with the same quantity of active ingredients as the genuine original brand. Herbal Preparations that are toxic, harmful, ineffective or mixed with orthodox medicine. Expired drugs or drugs without expiry date, or expired and re- labelled with the intention of extending their shelf-life. Drugs without full name and address of the manufacturer. Drugs not registered by NAFDAC

8 IMPLICATIONS OF COUNTERFEIT DRUGS Counterfeiting of medicines is one of the greatest atrocities of our time. It is also a form of terrorism against public health, as well as an act of economic sabotage. Counterfeit drugs violate the right to life of innocent victims. The evil of fake drugs is worse than the combined scourge of malaria, HIV/AIDS and armed robbery put together. This is because malaria can be prevented, HIV/AIDS can be avoided and armed robbery may kill a few at a time, but counterfeit/fake drugs kill en mass. The social problem posed by hard drugs, cocaine, heroine etc. cannot also be compared with the damage done by fake drugs, because illicit drugs are taken out of choice, and by those that can afford them, but fake drugs are taken by all and anybody can be a victim. Treatment failures, drug resistance, organ dysfunction/damage, worsening of disease conditions and death.

9 NIGERIAN EXPERIENCE Counterfeit drugs are most prevalent in developing countries. Developed countries are beginning to experience increase in reported cases, which are worsened by increasing sale of medicines on the Internet. AFRICA Prevalence of fake and counterfeit drugs in Africa worsens the existing burden of debt, poverty, illiteracy, diseases, wars, etc. Essential Drug Monitor (EDM) report on transforming drug supply in Dar es Salaam Tanzania, sums up the picture in most African countries as follows, –“There was chronic shortage of drugs at health facilities, supplies were erratic, as was government funding, poor drug supply management and irrational use of drugs. –Drug quality was questionable and pharmacy premises were often unsuitable, hot, humid and cluttered with piles of drugs, some of them expired. –Pharmacists have low professional visibility. This clearly mirrors the situation in many African countries, Nigeria not being an exception. In view of flow of trade on pharmaceutical products between Nigeria and neighbouring countries, the situation in Nigeria naturally reflects that of most African countries. SCOPE OF THE PROBLEM OF FAKE/COUNTERFEIT DRUGS IN NIGERIA PRIOR 2001.

10 SCOPE OF THE PROBLEM CONT’D When the present management of NAFDAC came on board in April 2001, we were faced with an enormous task of reactivating a failed regulatory environment of over two decades. Fake/counterfeit/expired/unregistered drugs, substandard cosmetics, unwholesome food products and other regulated products were dumped into Nigeria. Nigeria was rated as one of the countries with the highest incidence of fake/counterfeit drugs. Consequently, made in Nigeria drugs were officially unaccepted in other West African countries. Fake drugs embarrassed our healthcare providers and eroded the confidence of the public on our healthcare delivery system. Due to unfair competition, local drug manufacturing became unattractive, and many multinational companies left Nigeria out of frustration e.g. Boehringer, ICI, Sandoz, Merck, Ciba – Gaeigy, Boots, etc.

11 Estimates of the extent of counterfeit medicines in circulation in Nigeria ranged from 48% to 80% from various studies before A study by Poole in Nigeria in 1989 indicated that 25% of samples studied were fake, 25% genuine and 50% inconclusive. In 1990, Adeoye Lambo, a former WHO Deputy Director reported that 54% of drugs in every major pharmacy in Lagos were fake, and that the figure had risen to 80% in the subsequent year. Taylor et al reported that 48% of drugs tested were fake and substandard. SCOPE OF THE PROBLEM CONT’D

12 Antimalarials, antibiotics and vitamins are among the most used drugs in Nigeria. Out of the three, antimalarials as a group had the least proportion of products with standard active ingredients. Proportion of drugs with standard active ingredients. Adapted from: Adenika FB. Pharmacy in Nigeria 1998 SCOPE OF THE PROBLEM CONT’D

13 In 2001, NAFDAC carried a baseline study to ascertain the level of incidence of fake drugs in Nigeria. –This study measured the level of compliance to drug registration, and we found that 67.95% of drugs in circulation were unregistered. This study was repeated in 2003 and The second phase of the study is being conducted in collaboration with WHO and DFID, and this involves laboratory testing. SCOPE OF THE PROBLEM CONT’D

14 REPORTED CASES In Nigeria due to poor reporting system, cases of worsening disease conditions or deaths due to fake drugs abound, but unfortunately we don’t have much statistics to support them. In addition, due to cultural cleavages, deaths are sometimes attributed to witchcrafts from the “wicked ones” or “enemies”. This again does not help our reporting system. A few examples of the reported cases of effects of counterfeit and substandard drugs are as follow: In the early 80’s, poorly compounded Chloroquine syrup killed several children in University of Nigeria Teaching Hospital (U.N.T.H),Enugu of which there is no statistics, partly because many of the deaths were not even reported.

15 REPORTED CASES CONTD. In 1990, the “Paracetamol syrup disaster” occurred when 109 children died in Ibadan and Jos, (Nigeria) after taking paracetamol syrup produced with the toxic ethylene glycol solvent instead of propylene glycol. –This tragedy occurred more than fifty years after that of U.S.A. In 1996, without authorization from NAFDAC, clinical trial of a new antibiotic Trovan was carried out by Pfizer on 200 children in Kano Northern Nigeria during an epidemic outbreak of meningicoccal meningitis. –Several (the exact number is disputed) of the sick children given the experimental drug died. Many more suffered lasting injuries. One Samaila Musa now a teenager was struck deaf and dumb. The case is currently in a U.S.A. court. In 2002, 3 patients reacted adversely to infusions manufactured by a Nigerian company. Investigations by NAFDAC on the offensive infusions collected from the hospital revealed that three (3) batches were heavily contaminated.

16 REPORTED CASES CONTD. Fake cardiac stimulant (Adrenaline) was reported to have contributed to the death of 3 children during open-heart surgery in Nigeria in –Further investigations by NAFDAC revealed that the muscle relaxant (suxametonium) had low potency and some of the infusions used for the surgery were contaminated. In 2004, 3 Nigerian hospitals reported cases of adverse reactions from the use of contaminated infusions produced by 4 Nigerian companies. –Consequently we sampled infusions and water for injection from all over the country. –Our results confirmed that some batches of infusions produced by the indicted companies were heavily contaminated with microorganisms. –147 of the 149 brands of water for injection screened were also not sterile.

17  CORRUPTION AND CONFLICT OF INTERESTS The first line of action by drug counterfeiters is to compromise regulators. When this fails, they resort to Intimidation, harassment, blackmail, threats and physical attacks. CAUSES OF PHARMACEUTICAL COUNTERFEITING

18  INSECURE AND UNFRIENDLY ENVIRONMENT At some point, when all the other antics of drug counterfeiters failed, they resorted to physical attacks, vandalism, and arson against NAFDAC facilities and staff. This culminated in a shooting attack on my person on December 26, My family members and some NAFDAC staff remain constantly under threat. –Gunmen fired at the vehicle I was travelling in, the back windscreen was shattered by bullets which pierced through my head scarf and burnt my scalp. –During the shooting, a commercial bus was riddled with bullets and the driver died instantly.

19 ASSASSINATION ATTEMPT- Car rear shattered wind shield.

20 ASSASSINATION ATTEMPT- Head Scarf showing bullet holes

21 ASSASSINATION ATTEMPT - Car front wind shield with bullet hole

22 ARSON ON NAFDAC Operational Headquarters Lagos (Outside view)

23 Wreckages of NAFDAC Operational Headquarters Lagos destroyed by fire (Inside view).

24 Wreckages of NAFDAC Kaduna Laboratory destroyed by fire (Outside view)

25 Wreckages of NAFDAC Kaduna Laboratory destroyed by fire (Inside view)

26  DISCRIMINATORY REGULATION BY EXPORTING COUNTRIES Some countries have strong regulations for drugs consumed internally and little or no regulation for drugs meant for export. Discriminatory regulation Informed the decision of the NAFDAC management to prohibit the importation into Nigeria of products marked “FOR EXPORT ONLY.” –Any product that cannot be used in the country of manufacture is officially unacceptable in Nigeria. Presently, there are 92 pharmaceutical manufacturing companies producing about 30% of Nigeria’s drug need while the rest are imported. Most of the fake/counterfeit drugs in Nigeria are imported from Asia, particularly India and China. From 2001 till date, we banned thirty Indian and Chinese companies and one Pakistani company (confirmed to be fake drug producers) from exporting drugs into Nigeria.

27  CHAOTIC DRUG DISTRIBUTION SYSTEM Drug distribution in Nigeria is very chaotic with drugs marketed like any other commodity of trade. Due to poor regulation over the years, drug markets evolved and got deeply established all over the country despite the illegality of such activities. Almost all drug manufacturers and importers supply to these drug markets. Drug sellers and even health professionals patronize the drug markets, which also service the hawkers that sell in streets and commercial buses. Efforts made by NAFDAC to create an orderly Drug Distribution System so as to enable us phase out the existing disorganized Drug Markets, suffered a set back due to its unacceptability by some Pharmacists who are the major stakeholders in drug matters.

28  FALSE DECLARATION BY IMPORTERS Some drug importers, in order to evade inspection and detection, make false declarations about the nature and contents of the products in their containers. They employ unimaginable concealment methods for their nefarious activities, such as stacking drugs in the inner part of containers containing other items like clothings, hair products, motor spare parts or household items, or wrapping the drugs inside clothings. We have made several seizures of drugs concealed inside t- shirts or baby wears

29

30  SOPHISTICATION IN CLANDESTINE DRUG MANUFACTURE. Sophistication in drug production has made it difficult for even brand owners to tell the difference between their brands and counterfeits.

ORIGINAL FAKE Blister has grey, red and white diagonal bands. Each blister has”SB102M” embossed on the edge Registered by NAFDAC NAFDAC # Printed on the pack Blister has grey and red diagonal lines only There is no company Identification on the blister Counterfeit product with copied NAFDAC # Not registered by NAFDAC

ORIGINAL FAKE Address on product: Eli Lilly Company Limited Basingstoke, England Colour changes on brown hologram on exposure to light at different angles Date markings are stated in words i.e. MAY 04 Jun 06 Registered by NAFDAC NAFDAC # Printed on the pack Copied the name and address on the original product No colour change on brown hologram Date markings are stated in numbers i.e. M05 03 E Counterfeit product not registered by NAFDAC Has no NAFDAC # No location address of manufacturer Hologram absent Date markings are stated in numbers Look –alike and sound-alike fake product not registered by NAFDAC. SIMILAR SOUNDING NAMES/LOOK-ALIKE COUNTERFEITS DETECTED BY NAFDAC Look – alike and sound- alike

33  LACK OF OR INADEQUATE LEGISLATION Almost in all countries, laws against drug counterfeiting are very weak. Consequently, criminals are shifting from smuggling of narcotics and running of weapons to counterfeiting of drugs because it is financially lucrative and of relatively low risk. The penalties for importing, producing or distributing fake and counterfeit drugs in Nigeria ranges from imprisonment for between three months and five years with the option of fine of USD70 - USD3600. In the interim we have strengthened our regulatory processes by putting in place some administrative guidelines within the law. Using the press to disgrace identified drug counterfeiters.

34 NAFDAC’S VISION, MISSION, GOAL AND STRATEGIES Our VISION is to safeguard public health MISSION is to safeguard public health by ensuring that only the right quality products are manufactured, imported, exported, advertised, distributed, sold and used in Nigeria. Current GOAL is to eradicate fake drugs and other substandard regulated products. STRATEGIES EMPLOYED BY NAFDAC TO COMBAT DRUG COUNTERFEITING IN NIGERIA.

35  Staff Re-Orientation and Motivation At the inception of this administration, the inevitable need for staff re- orientation was glaring. Total change of mind-set and in fact, an organizational cultural revolution. Measures undertaken to reposition staff for better effectiveness: –Retrenchment of corrupt, redundant and incorrigible staff. –Staff training and re-training. –Effective delegation of duties and Staff empowerment. –To encourage staff, hard work, dedication and integrity are adequately compensated while any form of laxity or corruption is severely sanctioned. When hard work and integrity are not recognized and rewarded, corruption and ineptitude are promoted. –Leadership by example is highly emphasized. Strategies employed Contd.

36  Restructuring NAFDAC and Modernization of our Regulatory Processes NAFDAC was restructured into eight functional directorates as against the previous six. The two new directorates created, the Ports Inspection and Enforcement further positioned the agency to effectively tackle the problems emanating from inspection lapses and poor enforcement activities. Other six Directorates are: Laboratory Services Narcotics and Controlled Substances Establishment Inspection Registration and Regulatory Affairs Administration and Finance Planning, Research and Statistics Strategies employed Contd.

37  Restructuring Cont’d Ten new state offices were established and the existing twenty-seven were strengthened to cover the thirty-six states and Federal Capital Territory. -Three special inspectorate offices were also established in the three towns with the biggest drug markets, Onitsha, Aba and Kano. Four laboratories are continuously upgraded, and two new ones are under construction. Constructed new warehouses and land border offices at some of our ports. New Standard Operating Procedures (SOPs) and Guidelines were developed. Automation of all our regulatory processes. Strategies employed Contd.

38  Public Enlightenment Campaign Our most effective strategy in combating products’ counterfeiting, and creating effective regulation. Involves dialogue, education and persuasion because this addresses the fundamental issue at stake, which is BEHAVIOURAL CHANGE. Sustained using: –Print and electronic media such as jingles, alert notices, erection of billboards, publication of differences between identified fake and genuine products in the national dailies, etc. –Workshops, seminars and meetings have been conducted for most stakeholders ranging from pharmacists, patent medicine dealers, traditional rulers, religious leaders, manufacturers, importers, transporters and even consumers. –Grassroots mobilization campaign for rural areas is on- going. –We have produced many publications, fliers, leaflets, posters (both in English and vernacular languages). Strategies employed Contd.

39  Public Enlightenment Campaign Cont’d Extended to Nigerian High schools in order to catch them young, by organizing annual competitions and prize giving ceremonies on their understanding of the ill effects of fake drugs and other substandard products on the society. –Also established NAFDAC Consumer Safety Clubs in most of these schools. These activities are geared towards educating the young ones on the dangers of fake drugs, inculcating in them the value of quality and encouraging them to join NAFDAC in the fight against counterfeit medicines. Our enlightenment campaigns have greatly empowered the public to recognize and reject expired, fake/substandard drugs and unwholesome food. In any country we visit, we hold meetings with exporters of drugs, food, cosmetics and other NAFDAC regulated products. Convinced many of them to set up industries in Nigeria. Strategies employed Contd.

40  Stopping the Importation of Counterfeit Medicines and Other Substandard Products to Nigeria at Source In a bid to stop the importation of fake drugs from the countries of production to Nigeria, NAFDAC has put in place some administrative guidelines which include the following: A factory must be GMP certified before it can export drugs, cosmetics or any other NAFDAC regulated product to Nigeria. NAFDAC officials must inspect factories anywhere in the world before we register or renew registration for their drugs, cosmetics, food and other regulated products. NAFDAC has appointed analysts in India and China who re-certify any drug from the two countries before importation into Nigeria. For drugs imported from any country, NAFDAC requires mandatory pre- shipment information to be provided by all importers before the arrival of the drugs. Nigerian banks insist on NAFDAC clearance before processing financial documents for drug importers. This agreement is now a government policy because of its adoption by Central Bank of Nigeria. Strategies employed Contd.

41  Beefing Up Of Surveillance At All Ports Of Entry NAFDAC has re-enforced the two new directorates of Ports Inspection and Enforcement for more effective surveillance at all ports of entry, and better enforcement activities respectively. This has resulted in increased seizures of fake/counterfeit drugs and other substandard regulated products at the ports. Hitherto, land and sea borders were major routes of importation. The Agency, having considerably intensified surveillance at these borders, and the merchants of fake drugs resorted to the use of airlines. Consequently, NAFDAC issued a new guideline that any aircraft that lifts drugs to Nigeria without obtaining the Agency’s authorization from their clients will be grounded. Due to NAFDAC’s strong surveillance at the borders, and government’s ban on importation of drugs and other regulated products through land borders, these criminals have resorted to the use of speedboats and other water transports. Strategies employed Contd.

42  Mopping Up Substandard and Fake Products Already In Circulation Cognizance of our many porous borders, NAFDAC embarks on planned, systematic, continuous and sustained surveillance at all markets and retail outlets for drugs. This has given rise to sealing of pharmacy retail outlets involved in selling counterfeit, unregistered or expired drugs, and also drug manufacturing factories, whose GMP status were found to be unsatisfactory. Closure of 2 major drug markets for between 3 – 6 months. To achieve high level of success with our mopping up exercise, NAFDAC has put in place the following administrative guidelines: –Confiscation and subsequent destruction of drugs of sellers who fail to provide a proper invoice of purchase with full name and address. –This is to enable us trace the big time importers and distributors of fake drugs. Strategies employed Contd.

43  Mopping Up Fake Drugs Contd Faced with the frustrations of evacuating many lorry loads of fake drugs from warehouses on tip off without anybody accepting ownership, NAFDAC has notified the public that whenever the importer cannot be traced, the landlord of the premises used for the storage of fake drugs will be arrested, with a view to tracing the fake drug importer for necessary sanctions. –In one occasion in Lagos, it was only after the landlord of the warehouse was arrested that the owner of the fake drugs gave himself up. Raids are regularly carried out on drug hawkers, and their drugs are confiscated and destroyed. We also trace fake drug dealers through reports from health professionals or victims and constant tip-off from the public. Routine sampling, checking and testing of all NAFDAC registered drugs in circulation. Strategies employed Contd.

44 COUNTERFEITING-A REALITY!  Destruction of Seized Counterfeit Drugs by NAFDAC. (Health risk, national economic loss.) Strategies employed Contd.

45  Monitoring GMP of Local Manufacturers NAFDAC monitors local manufacturers of drugs routinely. Compliance directives are issued and enforced to the letter when lapses are observed. Prosecution is carried out as a last resort when necessary. Strategies employed Contd.

46  Streamlining and Strict Enforcement of Registration Guidelines NAFDAC has strengthened its registration processes with some administrative guidelines to ensure a strong and effective regulation, which is the most sustainable solution to dumping of fake products. These guidelines include: –All drugs must comply with laboratory standards and inspection requirements before they are registered. –Renewal of registration of any drug is every five years. –Renewal of Herbal Medicine registration is every year. –NAFDAC insists on fixing of NAFDAC REGISTRATION NUMBER on the label of all products to enable the public identify drugs certified by the Agency. –Drugs can be imported for only ten years, after which the importer must start producing locally. Strategies employed Contd.

47 OTHER INTERVENTIONS  INTERNATIONAL: –Established cooperation with food and drug regulators of almost all continents. –Constant dialogue with other West African countries’ Food and Drug Regulatory Authorities with a view to sharing strategies and carrying them along, so that the counterfeiters will not find a safe haven any where in the sub region. –In 2002 in Hong Kong, NAFDAC originated the campaign for the setting up of an international convention on counterfeiting of pharmaceuticals just as we have for narcotics and psychotropic substances. We have continued to aggressively pursue this campaign in all international meetings and it is catching on. Strategies employed Contd.

48  DRUGS SAFETY MONITORING –Established the National Pharmacovigilance Centre and admitted as the 74th member of National Centres, participating in the WHO Drug Safety Monitoring Programme.  ACCESS TO ETHICAL DRUGS STRICTLY ON PRESCRIPTION –It is common practice in Nigeria for prescription drugs to be purchased without prescription. This fuels irrational drug use which sustains drug counterfeiting. –NAFDAC has started enforcing that ethical drugs are obtained strictly on prescription. In agreement with other stakeholders, we started with all injectables in addition to the sedatives that are already being enforced. Strategies employed Contd.

49 We enjoy tremendous support from government under the able leadership of President Olusegun Obasanjo. Nigerian government banned importation of drugs through land borders and designated two airports and two seaports for drug importation. Recently, government also banned 17 drugs that our local manufacturers have capacity for. GOVERNMENT SUPPORT

50 Sanitized the food and drug industry and created a reasonably well regulated environment which has saved the lives of millions of Nigerians and boosted our economy by encouraging local industries, genuine importers and foreign investors. Immense public awareness resulted in the participation of all stakeholders in the promotion of food and drug regulation in Nigeria. –Awakened the international consciousness that Nigeria is no longer a dumping ground for fake drugs. The level of incidence of fake drugs has been reduced by over 80% from what it was in The production capacities of our local pharmaceutical industries have increased tremendously. 22 new drug manufacturing outfits were established in the last four and half years. SOME OF THE ACHIEVEMENTS AND GAINS RECORDED SO FAR

51 ACHIEVEMENTS CONTD. The confidence of investors in the pharmaceutical industry has been reinforced as evidenced in the continuous upward movement in the share prices of the pharmaceutical companies quoted in the Nigerian stock exchange. Ban on made in Nigeria drugs have been lifted by other West African countries. Many Multinational Drug Companies are coming back to Nigeria due to improved regulatory environment. Lily, Ciba – Geigy and Sandoz (merged as Novartis), Pharmacia, e.t.c. Cheering reports of declining number of kidney failure patients and death rates in our hospitals. –Working in concert with all Government hospitals in Nigeria, by compiling the number of renal failure patients and deaths on monthly basis in order to establish a trend. Over US$80 million worth of fake drugs have been publicly burnt in the last four years.

52 Over 1100 containers of regulated products were placed on 'Hold' at the Port Harcourt and Lagos ports, and most of the owners have absconded. –From 2001 to July 2005, over 1,000 raids were carried out on distribution outlets of fake drugs. 45 convictions in respect of counterfeit drugs related cases. Over 55 cases against violators pending in courts. –Sanctions on erring manufacturers and importers are increasing steadily. 2,226 sanctions in 2002; 3,178 in 2003; and 3,460 in Sanitization of table water and sachet water production have greatly reduced cholera and other water borne diseases outbreaks, which used to be rampant in the country. NAFDAC monitors salt iodization in Nigeria and in this regard, UNICEF rated Nigeria as the first country in Africa to achieve universal salt iodization. We are currently working to achieve the same feat in vitamin A fortification of flour, sugar, vegetable oil and margerine. ACHIEVEMENTS CONT’D

53 CONCLUSION Information technology has contributed to seamless borders between countries and fuelled high technical expertise of counterfeiters to the extent that counterfeiting is no longer a problem of the developing countries, but a serious global emerging issue It is only by networking among regulators, Industries, Law Enforcement Agencies and other stakeholders and collaboration among nations that we can effectively tackle the problem of drug counterfeiting. We must constantly share our experiences and strategies and build on what we have so as to always be a step ahead of these merchants of death. Customs organizations need to work hand in hand with drug regulators and other security organizations so that counterfeiters do not use the opportunity of interagency rivarry to escape detection. Counterfeiting of pharmaceuticals is beginning to get the attention it deserves, as evidenced by the number of anti-counterfeiting meetings organized by various interest groups around the world. It is my earnest desire that we will make the decision to fight counterfeit drugs and match it with necessary action no matter the cost.

54 CONCLUSION CONTD Pharmaceutical manufacturers should put in place anti-counterfeiting measures, like holograms, markers, special inks, etc, to safeguard their products, and also carry out regular post marketing surveillance in collaboration with regulatory authority. Country laws on drug counterfeiting should be severe enough to serve as deterrent. There is need for the African Union to table the issue of counterfeiting in their discussion Agenda to encourage Political will of Heads of African nations to fight counterfeiting in their respective countries. All concerned should embrace massive public enlightenment as it has proved to be a successful tool in fighting the Culture of Silence and secrecy, which enshrouds the counterfeiting problem. Counterfeiters can be overcome despite the dangers and threats from the criminal network. If we can fight drug counterfeiters to a stand-still in Nigeria, with courage, determination and sincerity of purpose, the west African sub region and the global community can succeed in eradicating counterfeit drugs in international commerce Thank you for listening

55 Website: Website: CONTACT PHONE NUMBERS ABUJA: Fax: LAGOS: Fax: Mobile: OR